Berlin, Germany

Mihaela Pruteanu

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mihaela Pruteanu: Innovator in Antibacterial Therapies

Introduction

Mihaela Pruteanu is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of microbiology and pharmaceutical sciences. Her innovative work focuses on repurposing compounds for the treatment of infections and modulating the gut microbiome.

Latest Patents

Mihaela Pruteanu holds a patent for her invention titled "Repurposing compounds for the treatment of infections and for modulating the composition of the gut microbiome." This patent relates to agents and compositions that modify the growth of bacterial cells. The compounds she developed are useful for preventing and treating various diseases, including infectious diseases, gastrointestinal disorders, and inflammatory diseases. Notably, some compounds demonstrate high specificity in inhibiting the growth of single bacterial species, enabling narrow-spectrum antibacterial therapies. This approach aims to reduce the side effects associated with traditional antibacterial treatments. Additionally, her compounds can be utilized for broad-spectrum antibiotic therapies, particularly for infections with unknown causative bacterial species.

Career Highlights

Mihaela Pruteanu is affiliated with the European Molecular Biology Laboratory, where she conducts her research. Her work has garnered attention for its potential impact on drug development strategies aimed at addressing bacterial infections and improving gut health.

Collaborations

Mihaela collaborates with esteemed colleagues, including Lisa Maier and Michael Kuhn, who contribute to her research endeavors.

Conclusion

Mihaela Pruteanu is a trailblazer in the field of antibacterial therapies, with her innovative patent paving the way for new treatment strategies. Her contributions are vital in the ongoing efforts to combat infectious diseases and improve health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…